Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

55.03 -0.90 (-1.61%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,339,576
Open	55.50
Bid (Size)	54.55 (500)
Ask (Size)	56.90 (100)
Prev. Close	55.93
Today's Range	54.95 - 56.09
52wk Range	50.76 - 73.51
Shares Outstanding	183,352,255
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

2 Reasons to Like BMRN and 1 to Stay Skeptical

November 24, 2025

BioMarin Pharmaceutical currently trades at $55.56 per share and has shown little upside over the past six months, posting a small loss of 4.4%. The stock also fell short of the S&P 500’s 11.5% gain...

Via StockStory

Q3 Earnings Outperformers: BioMarin Pharmaceutical (NASDAQ:BMRN) And The Rest Of The Therapeutics Stocks

November 23, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q3, starting with BioMarin...

Via StockStory

Performance

YTD	-17.2%	-17.2%
1 Month	+4.1%	+4.1%
3 Month	-6.9%	-6.9%
6 Month	-3.5%	-3.5%
1 Year	-15.4%	-15.4%

More News

AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

November 21, 2025

Via StockStory

BioMarin Pharmaceutical (BMRN): Buy, Sell, or Hold Post Q3 Earnings?

November 20, 2025

Via StockStory

Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. ↗

November 20, 2025

Via The Motley Fool

1 Safe-and-Steady Stock on Our Watchlist and 2 We Question

November 12, 2025

Via StockStory

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know

November 11, 2025

Via StockStory

The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market

November 14, 2025

Via MarketMinute

3 Cash-Producing Stocks with Promising Prospects

November 09, 2025

Via StockStory

This Zimmer Biomet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

November 06, 2025

Via Benzinga

BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) Presents a Compelling Value Investment Case ↗

November 05, 2025

Via Chartmill

The 5 Most Interesting Analyst Questions From BioMarin Pharmaceutical’s Q3 Earnings Call

November 03, 2025

Via StockStory

Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday ↗

October 28, 2025

Via The Motley Fool

Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today

October 28, 2025

Via StockStory

Biomarin Pharmaceutical Analysts Cut Their Forecasts After Downbeat Earnings ↗

October 28, 2025

Via Benzinga

BMRN Q3 Deep Dive: Product Expansion and Portfolio Shifts Define Outlook

October 28, 2025

Via StockStory

BioMarin (BMRN) Q3 2025 Earnings Call Transcript ↗

October 27, 2025

Via The Motley Fool

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Reports Mixed Q3 2025 Results with Revenue Growth but Earnings Miss ↗

October 27, 2025

Via Chartmill

BioMarin Pharmaceutical (NASDAQ:BMRN) Posts Q3 Sales In Line With Estimates

October 27, 2025

Via StockStory

Earnings Scheduled For October 27, 2025 ↗

October 27, 2025

Via Benzinga

BioMarin Pharmaceutical (BMRN) Reports Q3: Everything You Need To Know Ahead Of Earnings

October 25, 2025

Via StockStory

What to Expect from Biomarin Pharmaceutical's Earnings ↗

October 24, 2025

Via Benzinga

3 of Wall Street’s Favorite Stocks to Target This Week

October 24, 2025

Via StockStory

1 Healthcare Stock Worth Investigating and 2 We Question

October 17, 2025

Via StockStory

1 Mid-Cap Stock to Research Further and 2 That Underwhelm

October 15, 2025

Via StockStory

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?

Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.

What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?

BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?

The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market

What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?

The current price of BioMarin Pharmaceutical Inc. - Common Stock is 55.03

When was BioMarin Pharmaceutical Inc. - Common Stock last traded?

The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 12/01/25 04:00 PM ET

What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?

The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 10.09B

How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?

BioMarin Pharmaceutical Inc. - Common Stock has 10B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.